Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances
- 18 November 2002
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 54 (10) , 1241-1242
- https://doi.org/10.1016/s0169-409x(02)00167-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Drugs as P-glycoprotein substrates, inhibitors, and inducersDrug Metabolism Reviews, 2002
- Polymorphisms in OATP-CJournal of Biological Chemistry, 2001
- Identification and Functional Characterization of a New CYP2C9 Variant (CYP2C9*5) Expressed among African AmericansMolecular Pharmacology, 2001
- Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expressionNature Genetics, 2001
- MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugsNature Medicine, 1999
- P-Glycoprotein, a gatekeeper in the blood–brain barrierAdvanced Drug Delivery Reviews, 1999
- IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3AAnnual Review of Pharmacology and Toxicology, 1998
- Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liverHepatology, 1997